Adial Pharmaceuticals, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instrument Other than Option, Nonvested, Intrinsic Value
Adial Pharmaceuticals, Inc. (ADIL) had Share-based Compensation Arrangement by Share-based Payment Award, Equity Instrument Other than Option, Nonvested, Intrinsic Value of $0.43 per share as of 2023-12-31, per its 10-K filed 2024-04-01.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue · last filed 2024-04-01
- 2023-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instrument Other than Option, Nonvested, Intrinsic Value $0.43.
- 2023-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instrument Other than Option, Nonvested, Intrinsic Value $0.00.
- 2023-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instrument Other than Option, Nonvested, Intrinsic Value $0.00.
- 2023-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instrument Other than Option, Nonvested, Intrinsic Value $0.01.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instrument Other than Option, Nonvested, Intrinsic Value | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instrument Other than Option, Nonvested, Intrinsic Value as first filed |
|---|---|---|
| 2023-12-31 | $0.43 10-K · filed 2024-04-01 | |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $0.00 10-Q/A · filed 2023-10-30 | |
| 2023-03-31 | $0.01 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $0.25 10-K · filed 2024-04-01 | $0.01 10-K · filed 2023-03-30 |
| 2022-09-30 | $0.01 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $0.01 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $0.27 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $3.50 10-K · filed 2024-04-01 | $0.14 10-K · filed 2022-03-28 |
| 2021-09-30 | $0.42 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $0.02 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $0.02 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $0.02 10-K · filed 2023-03-30 | |
| 2019-12-31 | $0.03 10-K · filed 2022-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |